Patient Wins $6.5M Award In 1st Actos Bladder Cancer Trial
A California jury on Friday awarded $6.5 million to a man and his wife who claim the diabetes drug Actos caused his terminal bladder cancer, finding in the first product liability...To view the full article, register now.
Already a subscriber? Click here to view full article